Levoxacin

Levofloxacin, the active ingredient in Levoxacin, is a Fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections in adults and pediatric patients as determined by a prescriber. The drug targets susceptible Gram‑negative and Gram‑positive organisms, providing an option for community‑acquired respiratory infections, urinary tract infections, and skin infections.

GNH USA supplies Levoxacin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance and reliable delivery across global markets.

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary and skin systems.

Community‑acquired pneumonia: effective in eradicating the causative pathogens and improving clinical outcomes. Acute bacterial sinusitis: reduces symptoms and bacterial load in the sinuses. Acute exacerbation of chronic bronchitis: shortens duration of infection and improves lung function. Complicated urinary tract infections: eliminates resistant Gram‑negative organisms. Skin and soft tissue infections: treats a broad range of bacterial skin infections.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: loose stools that are usually self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional sensation of light‑headedness. - Photosensitivity: increased skin sensitivity to sunlight. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Tendon rupture: especially of the Achilles tendon, potentially leading to loss of function. - QT‑interval prolongation: may precipitate cardiac arrhythmias. - Severe allergic reactions: including anaphylaxis and Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis requiring medical attention. - Peripheral neuropathy: persistent nerve pain or tingling. - Hepatotoxicity: elevated liver enzymes indicating liver injury.

When prescribing levofloxacin, clinicians should consider several safety precautions.

Renal impairment: adjust dose based on creatinine clearance. History of tendon disorders: avoid use due to risk of tendon rupture. Prolonged QT interval: monitor cardiac rhythm. Pregnancy and lactation: use only if benefits outweigh risks. Concurrent use with NSAIDs: increased risk of central nervous system effects. Store at below 25°C: keep in the original pack, protect from moisture.

Levofloxacin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce levofloxacin absorption. - Drugs that prolong QT interval (e.g., quinidine, amiodarone): increase risk of cardiac arrhythmia. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Other fluoroquinolones: additive toxicity, avoid concurrent use. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened central nervous system adverse effects.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use raises tendon rupture risk. - Cyclosporine: may increase levofloxacin serum concentrations. - Theophylline: possible elevation of theophylline levels leading to toxicity. - Oral contraceptives: may reduce contraceptive efficacy. - Diabetic agents: heightened risk of hypoglycemia.